GlassScriptPhysician profile
Kristopher J Kimball
NPI 1073721635
$3,913.42
in general payments reported to CMS, 2019-2025
26 companies · $818 in 2025
The $818 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $374 · 2021: $235 · 2022: $300 · 2023: $643 · 2024: $861 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,322.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $772.65 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Intuitive Surgical, INC. | $548.58 | 2019-2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $471.51 | 2020-2025 | Jemperli, Zejula |
| Astrazeneca Pharmaceuticals LP | $358.45 | 2019-2024 | |
| Abbvie INC. | $341.00 | 2024-2025 | |
| Eisai INC. | $289.04 | 2021-2025 | |
| Clovis Oncology, INC. | $174.93 | 2019-2022 | |
| Pfizer INC. | $117.07 | 2024-2025 | |
| Ethicon US, LLC | $109.57 | 2025 | Ethicon, Vistaseal, Surgiflo Hemostatic Matrix |
| Seagen INC. | $91.15 | 2021-2023 | Tivdak |
| Immunogen, INC. | $88.12 | 2023 | Elahere |
| Tempus Ai, INC | $86.85 | 2024-2025 | Xt Cdx |
| Daiichi Sankyo INC. | $75.05 | 2025 | Enhertu |
| Astellas Pharma US INC | $56.86 | 2023-2024 | Veozah |
| Caris Mpi, INC. | $49.16 | 2025 | Mi Cancer Seek |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $46.92 | 2023-2025 | Mychoice Cdx, Myrisk |
| Conmed Corporation | $39.67 | 2024-2025 | Abc Handpieces |
| Foundation Medicine, INC. | $29.82 | 2019-2022 | |
| Tesaro, INC. | $29.68 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $26.53 | 2023 | Libtayo |
| Baxter Healthcare | $25.48 | 2024 | Perclot |
| Biom'Up France Sas | $23.09 | 2020 | |
| Kci USA, INC. | $20.48 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $15.44 | 2019 | |
| Genentech USA, INC. | $14.61 | 2019 | |
| Amgen INC. | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Kimball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.